new glp 1 gip drug Indications for GLP-1/GIP RA Summary Sheet and Beyond! tirzepatide glp 1 and gip
Description
As the first approved dual agonist of the GIP and GLP-1 receptors on the market, tirzepatide is considered to be a promising drug against type 2 diabetes and obesity
The results showed that liraglutide increased the expression of ALP, Col-1 and Runx2 mRNA, and decreased the expression of peroxisome proliferator-activated receptor (PPAR) (Lu et al., 2015)
Today, GLP-1 manufacturers are fully embracing this approach and working directly with vendors and employers to provide better access
In SOUL, composite HF endpoints were analysed as a secondary outcome, with oral semaglutide resulting in a non-significant reduction in HF events
